Deals channel feed

AS­CO star, backed by bil­lion­aires, goes to Astel­las in $1.4 bil­lion buy­out

9 years ago

Al­ler­gan’s ex­ec­u­tive team or­ches­trates a $200M buy­out to beef up gas­troen­terol­o­gy pipeline

9 years ago

To­bi­ra chair­man’s din­ner with Brent: In­dus­try chat led to a 3-month pur­suit and a stun­ning $1.7B deal

9 years ago

Scoop: Cel­gene tar­gets a cure for myelo­ma/lym­phoma with $600M En­gMab buy­out

9 years ago

An ac­quis­i­tive Cel­gene looks ready to pop a new mul­ti­ple myelo­ma deal

9 years ago

So Take­da wants to do up to $20B in M&A? Wel­come to the bid­ding war for US biotechs

9 years ago

Cel­gene pays $50M to tie up with four big can­cer re­search cen­ters

9 years ago
Pharma
First page Previous page 114115116117
A service from the Financial Times